TriSalus Life Sciences, Inc. TLSI
Set alert
3.70 USD -0.16 -4.15%
At close · Oct 30
3.70 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
3.66 Day range 3.87
2.52 52-week range 7.50
- YTD
- -46.99%
- 1 year
- -20.77%
- Open
- 3.77
- Prev close
- 3.86
- Mkt cap
- 227.83M
- Vol
- 108.59K
- Avg vol
- 262.58K
- EPS
- -1.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.66
- High
- 3.87
- Forward P/E
- -3.50
- Beta
- 0.50
- Short ratio
- 2.38
- Inst. own
- 17.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 4.14
- 200-d avg
- 6.29
- 1y target
- 11.64
2Y chart
Events in this range
- Nov 11, 2024Rating: Roth MKM · — → Buy
- Nov 14, 2024Earnings: -0.4; estimate -0.36; surprise -11.11%
- Nov 15, 2024Rating: Canaccord Genuity · Buy → Buy
- Dec 17, 2024Rating: Cantor Fitzgerald · — → Overweight
Signals (122)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| MACD: Sell Signal | May 13, 2026 | 5 months ago |
| RSI: Oversold | May 13, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 12, 2026 | 8 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 16, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| RSI: Overbought | Dec 16, 2025 | 10 months ago |
| RSI: Overbought | Dec 10, 2025 | 10 months ago |
| RSI: Overbought | Dec 4, 2025 | 11 months ago |
| RSI: Overbought | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| SMA: Bullish | Nov 20, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 19, 2025 | 11 months ago |
| RSI: Oversold | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 16, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 5, 2025 | 1 year ago |
| SMA: Bullish | Sep 4, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 15, 2025 | 1 year ago |
| RSI: Oversold | Aug 11, 2025 | 1 year ago |
| RSI: Oversold | Aug 6, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| SMA: Bullish | Jun 12, 2025 | 1 year ago |
| SMA: Bearish | Jun 11, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | May 30, 2025 | 1 year ago |
| SMA: Bullish | May 23, 2025 | 1 year ago |
| SMA: Bearish | May 22, 2025 | 1 year ago |
| SMA: Bullish | May 21, 2025 | 1 year ago |
| MACD: Buy Signal | May 20, 2025 | 1 year ago |
| SMA: Bearish | Apr 30, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| SMA: Bearish | Mar 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 15, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
Key statistics
- Market cap
- 125.94M
- Enterprise value
- 121.48M
- Trailing P/E
- 0.00
- Forward P/E
- -3.50
- PEG ratio
- 0.00
- Price / sales
- 5.09
- Price / book
- 0.00
- EPS (TTM)
- -1.92
- Beta
- 0.50
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -219.71%
- Revenue (TTM)
- 24.74M
- Revenue growth
- 59.70%
- Free cash flow
- -52.96M
- Total cash
- 16.48M
- Total debt
- 22.76M
- Return on equity
- 0.00%
- Shares outstanding
- 30.49M
- Short % of float
- 0.32%
- 50-day average
- 4.14
- 200-day average
- 6.29
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 11.64 +214.7% upside
Now 3.70
- Target (low)
- 10.00
- Target (mean)
- 11.64
- Target (high)
- 16.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy2
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2024
Expected Aug 14, 2024. Consensus EPS estimate -0.35.
Financials — quick view
TLSI Revenue — quarterly 11.41M
TLSI Net income — quarterly -9.19M
TLSI EPS — quarterly -0.16
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.36 | -0.40 | -0.04 | -11.11% |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.21 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.54 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -1.56 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | Cantor Fitzgerald | init | — | Overweight |
| Nov 15, 2024 | Canaccord Genuity | main | Buy | Buy |
| Nov 11, 2024 | Roth MKM | init | — | Buy |
| Oct 25, 2024 | Northland Capital Markets | init | — | Outperform |
| Sep 16, 2024 | Oppenheimer | init | — | Outperform |
| Jun 27, 2024 | Canaccord Genuity | main | Buy | Buy |
About TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- trisaluslifesci.com
News
- TriSalus Life Sciences to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
- TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
- Full Transcript: TriSalus Life Sciences Q2 2026 Earnings Call
- Reviewing Innovative Eyewear (NASDAQ:LUCY) and TriSalus Life Sciences (NASDAQ:TLSI)
- Crude Oil Gains 1%; Cintas Earnings Top Views
- TriSalus Secures FDA Clearance For TriNav Advance as Stock Tests Key Support
- TriSalus Secures FDA Clearance For TriNav Advance as Stock Tests Key Support
- TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
- TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
- Microsoft To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Your note
Sign in to keep a note on TLSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COX BRYAN F | Officer | Sale | Oct 3, 2024 | 86,382 |
| DESAI ARJUN JJ | Director | Sale | Dec 9, 2024 | 247,127 |
| FRANKENIUS EQUITY AB | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 16, 2024 | 6,230,750 |
| KATZ STEVEN C. | Officer | Stock Award(Grant) | Feb 11, 2024 | 68,587 |
| MARSHAK RICHARD | Officer | Stock Award(Grant) | Nov 13, 2024 | 34,126 |
| MARTIN GEORGE KELLY | Director | Sale | Aug 27, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wealthcare Advisory Partners LLC | 2.11% | 643,740 | 2.66M | Sep 29, 2024 |
| Duquesne Family Office Llc | 1.40% | 426,921 | 1.76M | Sep 29, 2024 |
| Vanguard Group Inc | 1.36% | 416,138 | 1.72M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.66% | 200,427 | 827.76K | Sep 29, 2024 |
| Millennium Management Llc | 0.32% | 97,888 | 404.28K | Sep 29, 2024 |
| Exos Asset Management LLC | 0.13% | 38,604 | 159.43K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.82% | 248,877 | 1.03M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.53% | 162,125 | 669.58K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.34% | 102,494 | 423.30K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.11% | 34,186 | 141.19K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.08% | 24,313 | 100.41K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 17,239 | 71.20K | Oct 30, 2024 |